Trevi Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
TRVI Nasdaq 2834 www.trevitherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Trevi Therapeutics, Inc.

Trevi Therapeutics Announces Upcoming June and July Event Schedule - Jun 17th, 2026 5:30 am
Trevi Therapeutics Is Up 100%, Pivotal bioVenture Adds Anyway. Here's Why That Matters. - Jun 3rd, 2026 8:04 am
Trevi Therapeutics Maps Haduvio Chronic Cough Push, Sees Cash Runway Into 2030 - May 9th, 2026 3:05 am
Trevi Therapeutics, Inc. Q1 2026 Earnings Call Summary - May 6th, 2026 10:58 am
Why Trevi Therapeutics (TRVI) Is Up 5.9% After Extending Its Cash Runway Into 2030 - May 6th, 2026 10:14 am
Trevi Therapeutics Q1 Earnings Call Highlights - May 5th, 2026 10:08 pm
Trevi Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Updates - May 5th, 2026 2:05 pm
Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference - Apr 30th, 2026 2:05 pm
Trevi Therapeutics to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 5, 2026 - Apr 28th, 2026 2:05 pm
Trevi Therapeutics to Participate in Upcoming May Events - Apr 23rd, 2026 2:05 pm
Did Trevi’s US$173 Million Raise and Share Expansion Just Reshape Trevi Therapeutics' (TRVI) Investment Narrative? - Apr 22nd, 2026 7:06 am
Trevi Therapeutics Announces Closing of $173 Million Underwritten Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares - Apr 20th, 2026 2:05 pm
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Investors Take Positions Amid Corporate Earnings - Apr 17th, 2026 6:22 am
Trevi Therapeutics Announces Pricing of $150 Million Underwritten Offering of Common Stock - Apr 16th, 2026 8:42 pm
Trevi Therapeutics Announces Proposed Public Offering of Common Stock - Apr 16th, 2026 2:08 pm
A Look At Trevi Therapeutics (TRVI) Valuation After FDA End Of Phase 2 Milestone For IPF Chronic Cough - Apr 5th, 2026 4:04 am
Trevi Therapeutics to Participate in Upcoming Events - Apr 1st, 2026 5:30 am
As Terns Stock Soars 1,400%, What Does One Fund's $5.2 Million Sale Signal to Investors? - Mar 23rd, 2026 10:07 am
Trevi Therapeutics Q4 Earnings Call Highlights - Mar 18th, 2026 4:36 pm
Trevi Therapeutics (TRVI) Earnings Transcript - Mar 18th, 2026 7:39 am